Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
- 2021
- Published
Evolving biosimilar clinical requirements: A qualitative interview study with industry experts and European national medicines agency regulators
Druedahl, Louise C., Kälvemark Sporrong, Sofia, van de Weert, Marco, De Bruin, M. L. (., Hoogland, H., Minssen, Timo & Almarsdóttir, Anna Birna, 2021, In: BioDrugs. 35, p. 351-361Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Informed consent during clinical care: A case study for the WHO
Corrales Compagnucci, Marcelo, Gerke, S. & Minssen, Timo, 2021, Ethics and Governance of Artificial Intelligence for Health: WHO Guidance. Geneva: World Health Organization, p. 48 1 p.Research output: Chapter in Book/Report/Conference proceeding › Article in proceedings › Research › peer-review
- Published
Letter and an op-eds for the Financial Times informing potential compromises regarding the IP Waiver debate
Minssen, Timo, 2021Research output: Other contribution › Net publication - Internet publication › Research
- Published
Podcast: Good patents - Bad patents: does protecting the pharmaceutical industry also benefit the most vulnerable?
Minssen, Timo, 2021Research output: Non-textual form › Sound/Visual production (digital) › Research
- Published
The Role of Patents and Licensing in the Governance of Human Genome Editing: A White Paper (July 30, 2021)
Matthews, D., Brown, A., Gambini, E., Mahon, A. M., Minssen, Timo, Nordberg, A., Sherkow, J. S., Wested, Jakob & Van Zimmeren, E., 2021, 52 p.Research output: Other contribution › Net publication - Internet publication › Research
- 2020
- Published
Preparing for Antimicrobial Resistance: Vision and Social Science Mission of the INAMRSS Network
Minssen, Timo, Outterson, K., Van Katwyk, S. R., Batista, P. H. D., Chandler, C., Ciabuschi, F., Harbarth, S., Kesselheim, A., Laxminarayan, R., Liddell, K., Osterholm, M. T., Price, L. B. & Hoffman, S. J., 11 Dec 2020, Harvard Law School's Bill of Health blog.Research output: Other contribution › Net publication - Internet publication › Research › peer-review
- Published
Social, cultural and economic aspects of antimicrobial resistance
Minssen, Timo, Outterson, K., Van Katwyk, S. R., Batista, P. H. D., Chandler, C., Ciabuschi, F., Harbarth, S., Kesselheim, A., Laxminarayan, R., Liddell, K., Osterholm, M. T., Price, L. & Hoffman, S. J., 3 Dec 2020, In: Bulletin of the World Health Organization. 98, 12, p. 823-824 2 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Legal Remedies In Times of Global Pandemic Crisis-Price Gouging, Compulsory Licensing and the role of Antitrust
Kianzad, Behrang & Minssen, Timo, 23 Oct 2020.Research output: Contribution to conference › Paper › Research
- Published
ELSI Implications of Prioritizing Biological Therapies in the Times of COVID-19
Druedahl, Louise C., Lebret, Audrey & Minssen, Timo, Oct 2020, In: Journal of Law, Medicine & Ethics. 48, 3, p. 579-582Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Knowledge transfer for large scale vaccine manufacturing
Price II, W. N., Rai, A. & Minssen, Timo, 13 Aug 2020, In: Science. 369, 6506, p. 912-914Research output: Contribution to journal › Journal article › Research › peer-review
ID: 16150437
Most downloads
-
4329
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2187
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2078
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published